A Multicentre UK Study of Outcomes for Locally Advanced Sinonasal Squamous Cell Carcinoma Treated with Adjuvant or Definitive Intensity-modulated Radiotherapy


Slevin, F, Pan, S, Mistry, H, Denholm, M, Shor, D, Oong, Z, Price, J, Jadon, R, Fleming, JC ORCID: 0000-0001-7963-1224, Barnett, G et al (show 3 more authors) (2021) A Multicentre UK Study of Outcomes for Locally Advanced Sinonasal Squamous Cell Carcinoma Treated with Adjuvant or Definitive Intensity-modulated Radiotherapy. CLINICAL ONCOLOGY, 33 (10). E450-E461.

This is the latest version of this item.

[img] Text
Sinonasal squamous cell carcinoma outcomes revised version.docx - Author Accepted Manuscript
Available under License : See the attached licence file.
Download (163kB)
[img] Slideshow
Sinonasal figure changes accepted.pptx - Author Accepted Manuscript
Available under License : See the attached licence file.
Download (58kB)
[img] Text
Sinonasal squamous cell carcinoma outcomes accepted.docx - Author Accepted Manuscript
Available under License : See the attached licence file.
Download (128kB)

Abstract

<h4>Aims</h4>Sinonasal malignancies are rare; the most common histological subtype is squamous cell carcinoma (SCC). No randomised trial data exist to guide treatment decisions, with options including surgery, radiotherapy and chemotherapy. The role and sequence of a primary non-surgical approach in this disease remains uncertain. The aim of this study was to present treatment outcomes for a multicentre population of patients with locally advanced, stage IVa/b sinonasal SCC treated with radical-intent intensity-modulated radiotherapy, either definitively or postoperatively.<h4>Materials and methods</h4>Consecutively treated patients with locally advanced, stage IVa/b sinonasal SCC at four UK oncology centres between January 2012 and December 2017 were retrospectively identified. Descriptive statistics and survival analyses were carried out. Univariable Cox regression analysis was carried out to evaluate the relationship between patient, disease and treatment factors and survival outcomes.<h4>Results</h4>In total, 56 patients with sinonasal SCC were included (70% maxillary sinus, 21% nasal cavity, 9% ethmoid/frontal sinus). Forty-one patients (73%) were treated by surgery/adjuvant (chemo)radiotherapy and 15 (27%) by definitive (chemo)radiotherapy. The median duration of follow-up was 3.8 years (interquartile range 2.0-4.7 years). Estimates for 5-year overall survival and progression-free survival were 30.2% and 24.2%, respectively. Local, regional and distant treatment failures were seen in 33%, 33% and 16% of patients, respectively. Univariable analysis revealed inferior progression-free survival for patients treated with neck dissection (hazard ratio 2.6, 95% confidence interval 1.2-6.1, P = 0.022) but no other significant association between the studied factors and survival outcomes.<h4>Conclusion</h4>We show poor survival outcomes and high rates of locoregional treatment failure for patients with locally advanced stage IVa/b sinonasal SCC. There is a need to investigate improved treatments for this group of patients.

Item Type: Article
Uncontrolled Keywords: Intensity-modulated radiotherapy, locally advanced, outcomes, sinonasal squamous cell carcinoma
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User: Symplectic Admin
Date Deposited: 19 May 2022 12:49
Last Modified: 18 Jan 2023 22:34
DOI: 10.1016/j.clon.2021.05.012
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3126864

Available Versions of this Item

Dimensions
Altmetric
CORE (COnnecting REpositories)